ClinicalTrials.govpublic full text
Naltrexone and Propranolol Combined With Immunotherapy
advanced melanoma, melanoma, metastatic melanoma, skin cancer, immune checkpoint inhibitors, propranolol, naltrexone, beta-adrenergic blocker, opioid receptor antagonist, tumor microenvironment, nk cells, t-cells
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 892860
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.